From: Factors associated with Health-Related Quality of Life in Kidney Transplant Recipients in France
Drugs N (%) | Side effectsa N (%) | |
---|---|---|
Mean number of drugs/side effects per patient | 6.6 ± 1.8 (2–14) | 6.4 ± 1.7 (4–9) |
Immunosuppressive treatments | 1397 (98.1) | 344 (24.6) |
Calcineurin inhibitors | 1170 (82.2) | 242 (20.6) |
Mycophenolic acid and derivatives | 933 (65.5) | 115 (12.3) |
Corticoids | 832 (58.4) | 159 (19.1) |
Others (mTOR inhibitors, Azathioprine) | 334 (23.4) | 56 (16.7) |
Antihypertensive treatments | 1161 (81.5) | 72 (6.2) |
Beta-blockers | 727 (51.1) | 28 (3.8) |
Angiotensin-converting enzyme (ACE) inhibitors | 709 (49.8) | 34 (4.8) |
Calcium antagonists | 485 (34.1) | 20 (4.1) |
Others (Central antihypertensive, Peripheral vasodilators/alpha-blockers, Diuretics) | 544 (38.2) | 30 (5.5) |
Other treatments | 1170 (82.2) | 54 (4.6) |
Cardiovascular drugs | 792 (55.6) | 38 (48.0) |
Calcium drugs | 727 (51.1) | 2 (0.3) |
Diabetes drugs | 239 (16.8) | 13 (5,4) |
Erythropoiesis-Stimulating Agents (ESA) | 199 (14.0) | 1 (0.5) |
Antidepressants | 149 (10.5) | 4 (2.7) |